Chiao-en P. Wu

Linkou Branch
Taoyuan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 128 publications

Correction: Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer.

Correction: Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer.

Journal: Scientific reports

Published: June 16, 2026

Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876.

Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876.

Journal: Cancers

Published: January 26, 2026

Membrane and soluble VTCN1 (B7H4) converge on Src signaling to mediate gemcitabine resistance in intrahepatic cholangiocarcinoma.

Membrane and soluble VTCN1 (B7H4) converge on Src signaling to mediate gemcitabine resistance in intrahepatic cholangiocarcinoma.

Journal: Theranostics

Published: December 22, 2025

First Report of Entrectinib as a Treatment Option for Pure Squamous Cell Carcinoma Harboring ROS1 Rearrangement: Exploring the Role of Next-Generation Sequencing in Targeted Therapy.

First Report of Entrectinib as a Treatment Option for Pure Squamous Cell Carcinoma Harboring ROS1 Rearrangement: Exploring the Role of Next-Generation Sequencing in Targeted Therapy.

Journal: International journal of molecular sciences

Published: October 19, 2025

Globo H ceramide confers chemoresistance and poor prognosis to advanced gallbladder cancer via A2AR/cAMP/PKA pathway.

Globo H ceramide confers chemoresistance and poor prognosis to advanced gallbladder cancer via A2AR/cAMP/PKA pathway.

Journal: Theranostics

Published: September 30, 2025

Validation of WHO 2017 Classification and Identification of Prognostic Factors in Patients with Pancreatic Neuroendocrine Neoplasms: A Real-World Experience in Taiwan.

Validation of WHO 2017 Classification and Identification of Prognostic Factors in Patients with Pancreatic Neuroendocrine Neoplasms: A Real-World Experience in Taiwan.

Journal: Journal of Cancer

Published: August 18, 2025

Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer.

Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer.

Journal: Scientific reports

Published: June 27, 2025

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan.

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan.

Journal: British journal of clinical pharmacology

Published: May 13, 2025

PufA drives cholangiocarcinoma progression via NFκB signaling activation: a novel therapeutic target.

PufA drives cholangiocarcinoma progression via NFκB signaling activation: a novel therapeutic target.

Journal: Cancer gene therapy

Published: May 12, 2025

Tumor size larger than 6.5 cm and microvascular invasion are comparable prognosticators for hepatocellular carcinoma: a multi-institutional observational study.

Tumor size larger than 6.5 cm and microvascular invasion are comparable prognosticators for hepatocellular carcinoma: a multi-institutional observational study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 11, 2025

Risk of Moderate to Severe Ocular Surface Disease Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A Multicenter Cohort Study.

Risk of Moderate to Severe Ocular Surface Disease Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A Multicenter Cohort Study.

Journal: Ophthalmology and therapy

Published: May 06, 2025

Integrating Chinese herbal medicine in advanced lung cancer: A multicenter real-world study using target trial emulation.

Integrating Chinese herbal medicine in advanced lung cancer: A multicenter real-world study using target trial emulation.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 28, 2025

Showing 1-12 of 128

Last Updated: 09/26/2026